`Tel: 571.272.7822
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`PRAXAIR DISTRIBUTION, INC.
`Petitioner
`
`v.
`
`INO THERAPEUTICS LLC,
`Patent Owner
`_____________
`
`Case IPR2015-00529
`U.S. Patent No. 8,846,112
`_____________
`
`Before LORA M. GREEN, TINA E. HULSE, and
`ROBERT A. POLLOCK Administrative Patent Judges.
`
`
`
`PETITIONER PRAXAIR DISTRIBUTION INC.’S OBJECTIONS TO
`PATENT OWNER INO THERAPEUTICS, LLC’S EVIDENCE
`
`
`
`Case IPR2015-00529
`U.S. Patent No. 8,846,112
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner Praxair Distribution, Inc.
`
`(“Praxair”) hereby submits the following objections to the evidence Patent Owner
`
`INO Therapeutics, LLC (“Ikaria”) filed with its Patent Owner Response dated
`
`November 5, 2015.
`
`Exhibit 2024
`
`Exhibit 2024 purports to be a copy of the prosecution history of abandoned
`
`U.S. Patent Application No. 12/820,886. Praxair objects to the following pages of
`
`Ex. 2024:
`
`Ex. 2024 at pp. 348-539
`
`Ex. 2024 at pp. 665-687
`
`Ex. 2024 at pp. 803-877
`
`Ex. 2024 at pp. 903-945
`
`Ex. 2024 at pp. 1075-1096
`
`Ex. 2024 at pp. 1098-1140
`
`Ex. 2024 at pp. 1142-1165
`
`Ex. 2024 at pp. 1167-1174
`
`Ex. 2024 at pp. 1176-1186
`
`Praxair objects to these pages of Ex. 2024 because they are declarations and
`
`supporting materials submitted during patent examination that Ikaria is relying on
`
`as evidence in this proceeding in violation of 37 C.F.R. § 42.53(a), which states
`
`2
`
`
`
`Case IPR2015-00529
`U.S. Patent No. 8,846,112
`
`that “[u]ncompelled direct testimony must be submitted in the form of an
`
`affidavit.” These portions of Ex. 2024 also lack foundation (FRE 602) and
`
`authentication (FRE 901) and constitute impermissible hearsay (FRE 901).
`
`Exhibit 2029
`
`Exhibit 2029 is a publication by Michael R. Zile et al. titled “New Concepts
`
`in Diastolic Dysfunction and Diastolic Heart Failure: Part I - Diagnosis,
`
`Prognosis, and Measurements of Diastolic Function. Praxair objects to Ex. 2029
`
`because it does not appear that Ikaria relies on this document in its Patent Owner
`
`response, nor does it appear that Ikaria’s expert witness, Dr. Geoffrey L.
`
`Rosenthal, relies on this document in his declaration (Ex. 2020).
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`owed by Petitioner and associated with this case to Deposit Account 02-1818.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted by
`
`
`
`
`
`K&L Gates LLP
`
`/Sanjay K. Murthy/
`Sanjay K. Murthy
`Reg. No. 45,976
`Customer No. 24573
`K&L Gates LLP
`e-mail: sanjay.murthy@klgates.com
`telephone number: 312-807-4416
`fax number: 312-827-8196
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`By:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`Certification of Service Under 37 C.F.R. § 42.6(e)(4)
`
`
`
`A copy of the foregoing has been served to counsel of record for the Patent
`
`Owner at the following electronic mail addresses pursuant to the Patent Owner’s
`
`authorization of electronic service on this 13th day of November, 2015
`
`Bob.Steinberg@lw.com
`
`Daniel.Brown@lw.com
`
`Marc.Zubick@lw.com
`
`David.Callahan@lw.com
`
`KENNETH.SCHULER@lw.com
`
`
`
`
`
`
`
`
`
`/Sanjay K. Murthy/
`Sanjay K. Murthy
`Reg. No. 45,976
`Customer No. 24573
`K&L Gates LLP
`e-mail: sanjay.murthy@klgates.com
`telephone number: 312-807-4416
`fax number: 312-827-8196
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`By: